Bill Gates Investing $40 Million for mRNA Vaccine Development in Africa

The investment will fund new technologies that cut down mRNA vaccine costs by over 50 percent.
Bill Gates Investing $40 Million for mRNA Vaccine Development in Africa
Bill Gates speaks onstage at the TIME100 Summit 2022 at Jazz at Lincoln Center in New York City, on June 7, 2022. Jemal Countess/Getty Images for TIME
Naveen Athrappully
Updated:
0:00

The Gates Foundation is spending $40 million on countries in Africa and other economically backward nations to produce new mRNA vaccines in efforts to prevent against diseases like tuberculosis and malaria.

On Monday, the Bill & Melinda Gates Foundation announced $40 million in funding to “advance access to mRNA research and vaccine manufacturing technology that will support low-and middle-income countries’ (LMICs) capacity to develop high-quality, lifesaving vaccines at scale,” according to an Oct. 9 press release. The $40 million will be spent on boosting access to a low-cost mRNA research and manufacturing platform developed by Belgium-based Quantoom Biosciences.
Related Topics